|
30.1.2015 |
HR |
Službeni list Europske unije |
C 32/1 |
Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. prosinca 2014. do 31. prosinca 2014.
(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća (1))
(2015/C 032/01)
— Izdavanje odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno
|
Datum odluke |
Naziv lijeka |
INN (međunarodni nezaštićeni naziv lijeka) |
Nositelj odobrenja za stavljanje u promet |
Broj upisa u registar Zajednice |
Farmaceutski oblik |
Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova) |
Datum obavijesti |
|
5.12.2014. |
Paliperidone Janssen |
Paliperidon |
Janssen-Cilag International NV Turnhoutseweg 30, B-2340 Beerse, België |
EU/1/14/971 |
Suspenzija s produljenim oslobađanjem za injekciju |
N05AX13 |
9.12.2014. |
|
8.12.2014. |
Duloksetin Lilly |
duloksetin |
Eli Lilly Nederland B.V. Grootslag 1-5, NL-3991 RA Houten, Nederland |
EU/1/14/972 |
Želučanootporna tvrda kapsula |
N06AX21 |
10.12.2014. |
|
8.12.2014. |
Moventig |
naloksegol |
AstraZeneca AB SE-151 85 Södertälje, Sverige |
EU/1/14/962 |
Filmom obložena tableta |
A06AH03 |
10.12.2014. |
|
16.12.2014. |
DUAVIVE |
konjugirani estrogeni/bazedoksifen |
Pfizer Limited Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom |
EU/1/14/960 |
Tableta s prilagođenim oslobađanjem |
G03CX |
18.12.2014. |
|
16.12.2014. |
Lynparza |
Olaparib |
AstraZeneca AB SE-151 85 Södertälje, Sverige |
EU/1/14/959 |
Kapsula, tvrda |
L01 |
18.12.2014. |
|
19.12.2014. |
Cyramza |
ramucirumab |
Eli Lilly Nederland B.V. Grootslag 1-5, NL-3991 RA Houten, Nederland |
EU/1/14/957 |
Koncentrat za otopinu za infuziju |
L01XC |
23.12.2014. |
|
19.12.2014. |
Rixubis |
nonakog gama |
Baxter Innovations GmbH Industriestraße 67, A-1221 Wien, Österreich |
EU/1/14/970 |
Prašak i otapalo za otopinu za injekciju |
B02BD04 |
23.12.2014. |
|
22.12.2014. |
Scenesse |
afamelanotid |
Clinuvel UK Limited c/o – Reed Smith, Broadgate Tower, Third Floor, 20 Primrose Street, London, EC2A 2RS, United Kingdom |
EU/1/14/969 |
Implantant |
D02BB02 |
29.12.2014. |
— Izmjena odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno
|
Datum odluke |
Naziv lijeka |
Nositelj odobrenja za stavljanje u promet |
Broj upisa u registar Zajednice |
Datum obavijesti |
|
1.12.2014. |
Desloratadine Teva |
Teva Pharma B.V. Computerweg 10, NL-3542 DR Utrecht, Nederland |
EU/1/11/732 |
3.12.2014. |
|
1.12.2014. |
Ibandronic Acid Teva |
Teva Pharma B.V. Computerweg 10, NL-3542 DR Utrecht, Nederland |
EU/1/10/642 |
3.12.2014. |
|
1.12.2014. |
Irbesartan Teva |
Teva Pharma B.V. Computerweg 10, NL-3542 DR Utrecht, Nederland |
EU/1/09/576 |
3.12.2014. |
|
1.12.2014. |
Optimark |
Mallinckrodt Deutschland GmbH Josef-Dietzgen-Strasse 1, D-53773 Hennef, Deutschland |
EU/1/07/398 |
3.12.2014. |
|
4.12.2014. |
Menveo |
Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina, 1, 53100 Siena, Italia |
EU/1/10/614 |
9.12.2014. |
|
4.12.2014. |
Ratiograstim |
ratiopharm GmbH Graf-Arco-Straße 3, D-89079 Ulm, Deutschland |
EU/1/08/444 |
8.12.2014. |
|
4.12.2014. |
Tevagrastim |
Teva GmbH Graf-Arco-Straße 3, D-89079 Ulm, Deutschland |
EU/1/08/445 |
8.12.2014. |
|
5.12.2014. |
Cystagon |
Orphan Europe S.A.R.L. Immeuble Le Wilson, 70 avenue du Général de Gaulle, F-92 800 Puteaux, France |
EU/1/97/039 |
9.12.2014. |
|
5.12.2014. |
Erbitux |
Merck KGaA 64271 Darmstadt, Deutschland |
EU/1/04/281 |
9.12.2014. |
|
5.12.2014. |
Vectibix |
Amgen Europe B.V. Minervum 7061, NL-4817 ZK Breda, Nederland |
EU/1/07/423 |
9.12.2014. |
|
11.12.2014. |
Bronchitol |
Pharmaxis Pharmaceuticals Limited The Priory, Stomp Road, Burnham, Buckinghamshire SL1 7LW, United Kingdom |
EU/1/12/760 |
15.12.2014. |
|
11.12.2014. |
Efavirenz Teva |
Teva B.V. Swensweg 5, 2031 GA Haarlem, Nederland |
EU/1/11/742 |
15.12.2014. |
|
11.12.2014. |
Eviplera |
Gilead Sciences International Limited Cambridge CB21 6GT, United Kingdom |
EU/1/11/737 |
15.12.2014. |
|
11.12.2014. |
Levetiracetam ratiopharm |
ratiopharm GmbH Graf-Arco-Straße 3, D-89079 Ulm, Deutschland |
EU/1/11/702 |
15.12.2014. |
|
11.12.2014. |
Removab |
Neovii Biotech GmbH Am Haag 6-7, 82166 Graefelfing, Deutschland |
EU/1/09/512 |
15.12.2014. |
|
15.12.2014. |
Lantus |
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main, Deutschland |
EU/1/00/134 |
18.12.2014. |
|
15.12.2014. |
Lemtrada |
Genzyme Therapeutics Ltd 4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford OX4 2SU, United Kingdom |
EU/1/13/869 |
17.12.2014. |
|
15.12.2014. |
Levetiracetam Actavis Group |
Actavis Group PTC ehf. Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland |
EU/1/11/738 |
18.12.2014. |
|
15.12.2014. |
Mircera |
Roche Registration Limited 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom |
EU/1/07/400 |
18.12.2014. |
|
15.12.2014. |
Naglazyme |
BioMarin Europe Ltd 164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom |
EU/1/05/324 |
17.12.2014. |
|
15.12.2014. |
Optisulin |
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main, Deutschland |
EU/1/00/133 |
18.12.2014. |
|
15.12.2014. |
Revestive |
NPS Pharma Holdings Limited Grand Canal House, 1 Grand Canal Street Upper, Dublin 4, Ireland |
EU/1/12/787 |
17.12.2014. |
|
15.12.2014. |
Somatropin Biopartners |
BioPartners GmbH Kaiserpassage 11, D-72764 Reutlingen, Deutschland |
EU/1/13/849 |
17.12.2014. |
|
15.12.2014. |
Tasigna |
Novartis Europharm Limited Frimley Business Park, Camberley GU16 7SR, United Kingdom |
EU/1/07/422 |
18.12.2014. |
|
15.12.2014. |
Xeloda |
Roche Registration Limited 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom |
EU/1/00/163 |
18.12.2014. |
|
16.12.2014. |
Afinitor |
Novartis Europharm Limited Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EU/1/09/538 |
18.12.2014. |
|
16.12.2014. |
Brintellix |
H. Lundbeck A/S Ottiliavej 9, DK-2500 Valby, Danmark |
EU/1/13/891 |
18.12.2014. |
|
16.12.2014. |
Cimzia |
UCB Pharma S.A. Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België |
EU/1/09/544 |
17.12.2014. |
|
16.12.2014. |
Fasturtec |
Sanofi-Aventis groupe 54 rue La Boétie, F-75008 Paris, France |
EU/1/00/170 |
18.12.2014. |
|
16.12.2014. |
Hizentra |
CSL Behring GmbH Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland |
EU/1/11/687 |
18.12.2014. |
|
16.12.2014. |
HyQvia |
Baxter Innovations GmbH Industriestraße 67, A-1221 Wien, Österreich |
EU/1/13/840 |
18.12.2014. |
|
16.12.2014. |
Incivo |
Janssen-Cilag International NV Turnhoutseweg 30, B-2340 Beerse, België |
EU/1/11/720 |
18.12.2014. |
|
16.12.2014. |
Lamivudine Teva |
Teva B.V. Swensweg 5, 2031 GA Haarlem, Nederland |
EU/1/09/566 |
18.12.2014. |
|
16.12.2014. |
Levetiracetam Actavis |
Actavis Group PTC ehf. Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland |
EU/1/11/713 |
18.12.2014. |
|
16.12.2014. |
Methylthioninium chloride Proveblue |
Provepharm S.A.S. 22 Rue Marc Donadille, 13013 Marseille, France |
EU/1/11/682 |
18.12.2014. |
|
16.12.2014. |
NULOJIX |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom |
EU/1/11/694 |
18.12.2014. |
|
16.12.2014. |
Orphacol |
Laboratoires CTRS 63 rue de l'Est, F-92100 Boulogne-Billancourt, France |
EU/1/13/870 |
18.12.2014. |
|
16.12.2014. |
Paglitaz |
Krka, d. d., Novo Mesto Šmarješka cesta 6, 8501 Novo mesto, Slovenija |
EU/1/11/721 |
18.12.2014. |
|
16.12.2014. |
Pioglitazone Teva |
Teva Pharma B.V. Computerweg 10, NL-3542 DR Utrecht, Nederland |
EU/1/12/757 |
18.12.2014. |
|
16.12.2014. |
Pioglitazone Teva Pharma |
Teva Pharma B.V. Computerweg 10, NL-3542 DR Utrecht, Nederland |
EU/1/12/758 |
18.12.2014. |
|
16.12.2014. |
Remsima |
Celltrion Healthcare Hungary Kft. Árpád Fejedelem útja 26-28, H-1023 Budapest, Magyarország |
EU/1/13/853 |
18.12.2014. |
|
16.12.2014. |
Ristaben |
Merck Sharp & Dohme Limited Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom |
EU/1/10/621 |
19.12.2014. |
|
16.12.2014. |
Ristfor |
Merck Sharp & Dohme Limited Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom |
EU/1/10/620 |
17.12.2014. |
|
16.12.2014. |
Stivarga |
Bayer Pharma AG D-13342 Berlin, Deutschland |
EU/1/13/858 |
18.12.2014. |
|
16.12.2014. |
Ultibro Breezhaler |
Novartis Europharm Limited Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EU/1/13/862 |
18.12.2014. |
|
16.12.2014. |
Ulunar Breezhaler |
Novartis Europharm Limited Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EU/1/14/917 |
19.12.2014. |
|
16.12.2014. |
Votubia |
Novartis Europharm Limited Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EU/1/11/710 |
18.12.2014. |
|
16.12.2014. |
Xoterna Breezhaler |
Novartis Europharm Limited Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom |
EU/1/13/863 |
18.12.2014. |
|
16.12.2014. |
Zelboraf |
Roche Registration Limited 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom |
EU/1/12/751 |
19.12.2014. |
|
19.12.2014. |
CellCept |
Roche Registration Limited 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom |
EU/1/96/005 |
23.12.2014. |
|
19.12.2014. |
InductOs |
Medtronic BioPharma B.V. Earl Bakkenstraat 10, NL-6422 PJ Heerlen, Nederland |
EU/1/02/226 |
23.12.2014. |
|
19.12.2014. |
Puregon |
Merck Sharp & Dohme Limited Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom |
EU/1/96/008 |
23.12.2014. |
|
19.12.2014. |
Rilutek |
Aventis Pharma S.A. 20 avenue Raymond Aron, F-92165 Antony CEDEX, France |
EU/1/96/010 |
23.12.2014. |
|
19.12.2014. |
Stayveer |
Marklas Nederland B.V. Beneluxlaan 2b, NL-3446 GR Woerden, Nederland |
EU/1/13/832 |
5.1.2015. |
|
19.12.2014. |
Telmisartan Teva |
Teva Pharma B.V. Computerweg 10, NL-3542 DR Utrecht, Nederland |
EU/1/09/610 |
24.12.2014. |
|
19.12.2014. |
Travatan |
Alcon Laboratories (UK) Ltd Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom |
EU/1/01/199 |
23.12.2014. |
|
19.12.2014. |
Victoza |
Novo Nordisk A/S Novo Allé, DK-2880 Bagsvaerd, Danmark |
EU/1/09/529 |
23.12.2014. |
|
19.12.2014. |
Zoledronic acid Teva |
Teva B.V. Swensweg 5, 2031 GA Haarlem, Nederland |
EU/1/12/771 |
24.12.2014. |
|
19.12.2014. |
Zoledronic acid Teva Pharma |
Teva B.V. Swensweg 5, 2031 GA Haarlem, Nederland |
EU/1/12/772 |
24.12.2014. |
— Izdavanje odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno
|
Datum odluke |
Naziv lijeka |
INN (međunarodni nezaštićeni naziv lijeka) |
Nositelj odobrenja za stavljanje u promet |
Broj upisa u registar Zajednice |
Farmaceutski oblik |
Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova) |
Datum obavijesti |
|
22.12.2014. |
Bovela |
Modificirani živi BVDV-1 necitopatogeni roditeljski soj KE-9, Modificirani živi BVDV-2 necitopatogeni roditeljski soj NY-93 |
Boehringer Ingelheim International GmbH Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland |
EU/2/14/176 |
Liofilizat i otapalo, suspenzija za injekciju |
QI02AD02 |
29.12.2014. |
— Izmjena odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno
|
Datum odluke |
Naziv lijeka |
Nositelj odobrenja za stavljanje u promet |
Broj upisa u registar Zajednice |
Datum obavijesti |
|
4.12.2014. |
Gripovac 3 |
Merial 29 avenue Tony Garnier, F-69007 Lyon, France |
EU/2/09/102 |
8.12.2014. |
|
4.12.2014. |
Porcilis AR-T DF |
Intervet International B.V. Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland |
EU/2/00/026 |
8.12.2014. |
|
4.12.2014. |
Respiporc Flu3 |
IDT Biologika GmbH Am Pharmapark, D-06861 Dessau-Rosslau, Deutschland |
EU/2/09/103 |
8.12.2014. |
|
11.12.2014. |
Comfortis |
Eli Lilly and Company Ltd, Elanco Animal Health Lilly House Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom |
EU/2/10/115 |
15.12.2014. |
|
11.12.2014. |
Trifexis |
Eli Lilly and Company Ltd, Elanco Animal Health Lilly House Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom |
EU/2/13/155 |
15.12.2014. |
|
16.12.2014. |
Pexion |
Boehringer Ingelheim Vetmedica GmbH D-55216 Ingelheim am Rhein, Deutschland |
EU/2/12/147 |
18.12.2014. |
Zainteresirane osobe koje žele na uvid dobiti javno izvješće o procjeni predmetnih lijekova i odluka koje se na njih odnose trebale bi se obratiti:
|
The European Medicines Agency |
|
30, Churchill Place, Canary Wharf |
|
UK – LONDON E14 5EU |
(1) SL L 136, 30.4.2004, str. 1.